Concepedia

Anne Pernille Ofstad

AP

35

Publications

1.5K

Citations

22

H-Index

2004

Active since

Affiliations

Boehringer Ingelheim (Norway)(Current)

Boehringer Ingelheim (Germany)

University of Toronto

St. Michael's Hospital

Lunenfeld-Tanenbaum Research Institute

Anne Pernille Ofstad is an author at Boehringer Ingelheim (Norway) specializing in medicine, diabetes, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2004–2023

35

Publications

35

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status

Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · Circulation · 2020 · 332 citations · Full text

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes

Gerasimos Filippatos, Javed Butler, Dimitrios Farmakis et al. · Circulation · 2022 · 121 citations · Full text

Efficacy of Empagliflozin on Heart Failure and Renal Outcomes in Patients with Atrial Fibrillation: Data from the EMPA-REG OUTCOME Trial

Michael Böhm, Jonathan Slawik, Martina Brueckmann et al. · European Journal of Heart Failure · 2019 · 102 citations · Full text

Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure

Michael Böhm, Stefan D. Anker, Javed Butler et al. · Journal of the American College of Cardiology · 2021 · 84 citations · Full text

Mediators of the Improvement in Heart Failure Outcomes with Empagliflozin in the EMPA-REG OUTCOME Trial

David Fitchett, Silvio E. Inzucchi, Bernard Zinman et al. · ESC Heart Failure · 2021 · 84 citations · Full text

Rows per page

1–5 of 35